SCHEMBL9367753

SCHEMBL9367753

O=C(Cc1ccc(OCc2ccccc2)cc1)Nc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.71
EPHX2 P34913 1/20 0.70
RAB9A P51151 7/20 0.69
SMN1; SMN2 Q16637 6/20 0.69
NPC1 O15118 5/20 0.69
HPGD P15428 1/20 0.69
ALDH1A1 P00352 3/20 0.66
MAPT P10636 1/20 0.64
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
RXFP1 Q9HBX9 1/20 0.62
CYP1A2 P05177 1/20 0.61
CYP2C19 P33261 1/20 0.61
GAA P10253 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9370835 0.90 LTA4H (0.63) LTA4HEPHX2RAB9ASMN1; SMN2NPC1
SCHEMBL9367030 0.87 MEN1 (0.74) LTA4HRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL9366570 0.87 RAB9A (0.64) LTA4HRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL8704595 0.86 USP2 (0.81) RAB9ASMN1; SMN2NPC1HPGDALDH1A1
SCHEMBL20211905 0.85 EPHX2 (0.61) LTA4HEPHX2RAB9ASMN1; SMN2NPC1
SCHEMBL6170899 0.85 L3MBTL1 (0.80) LTA4HRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL12687892 0.84 HDAC6 (0.68) LTA4HSMN1; SMN2MEN1KMT2ACYP1A2
SCHEMBL10054999 0.83 EPHX2 (0.92) EPHX2RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL1516167 0.83 EPHX2 (1.00) EPHX2RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL1732806 0.83 ALDH1A1 (0.63) LTA4HALDH1A1MAPTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0409163-B1 Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors MERRELL DOW PHARMA (US) 1994-12-21 EP disclosed